A Clinical Potential of the Anti-Cancer Drug Sensitivity Test for Patients with Endocrine Cell Carcinoma of the Rectum: Report of a Case

Neuroendocrine carcinoma (NEC) of the colon is a rare disease with few reports. Although the tumor progresses rapidly and is highly aggressive and malignant, no effective treatment has been established. In this study, we report four cases of NEC between 2010 and 2020：one male and three females aged 61 to 87 years old. The tumor location was one in the cecum, one in the ascending colon, one in the descending colon, and one in the rectum. Two cases that could not be clearly diagnosed underwent surgery. All cases had lymph node metastases. Three cases died of NEC within 3 to 6 months. Patients with colorectal NEC are often diagnosed at an advanced stage. Multidisciplinary strategies, including systemic chemotherapy, are common in the treatment of colorectal NEC. However, no effective treatment has been established. Further cases need to be accumulated to clarify the best treatment options for colorectal NEC.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

A Clinical Potential of the Anti-Cancer Drug Sensitivity Test for Patients with Endocrine Cell Carcinoma of the Rectum: Report of a Case

Abstract: Key words

Cited by 2 publications

References 14 publications

Bevacizumab併用mFOLFOX6療法が奏効した上行結腸内分泌細胞癌の１例

Bevacizumab併用mFOLFOX6療法が奏効した上行結腸内分泌細胞癌の１例

Our Experience of Colorectal Neuroendocrine Carcinoma:A Report of Four Cases

Contact Info

Product

Resources

About